Boston Scientific
BSX
840 hedge funds and large institutions have $45.8B invested in Boston Scientific in 2020 Q2 according to their latest regulatory filings, with 114 funds opening new positions, 355 increasing their positions, 246 reducing their positions, and 67 closing their positions.
70% more first-time investments, than exits
New positions opened: 114 | Existing positions closed: 67
44% more repeat investments, than reductions
Existing positions increased: 355 | Existing positions reduced: 246
10% more capital invested
Capital invested by funds: $41.6B → $45.8B (+$4.24B)
5% more funds holding
Funds holding: 800 → 840 (+40)
0.23% more ownership
Funds ownership: 91.11% → 91.34% (+0.23%)
26% less funds holding in top 10
Funds holding in top 10: 23 → 17 (-6)
43% less call options, than puts
Call options by funds: $202M | Put options by funds: $357M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$628M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$478M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$478M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$419M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
+$292M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.26B |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
-$481M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$308M |
| 4 |
Jennison Associates
New York
|
-$291M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$147M |
BSX Hedge Fund Activity: Q2 2020 in Review
840 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q2 2020, worth a combined $45.8B — up 10% from $41.6B a quarter earlier.
Buyers outnumbered sellers: 114 funds opened new BSX positions and 67 closed out — a net gain of 47 holders — while 355 added to existing stakes and 246 trimmed.
The largest buyer was BlackRock, adding an estimated $628M. The largest seller was Fidelity Investments, cutting an estimated $1.26B.
- 840 institutional investors held Boston Scientific (BSX) as of Q2 2020, up from 800 in Q1 2020.
- Funds reported $45.8B of Boston Scientific stock for Q2 2020, up 10% quarter-over-quarter.
- 114 funds opened new Boston Scientific positions in Q2 2020 and 67 closed out, a net change of +47 holders.
- The largest Boston Scientific buyer in Q2 2020 was BlackRock, an estimated $628M added.
- The largest Boston Scientific seller in Q2 2020 was Fidelity Investments, an estimated $1.26B sold.
Based on aggregated 13F filings for Q2 2020.